NASDAQ: TSRO       Tesaro Inc
Last Price Today's Change   Day's Range   Trading Volume
150.73   -1.61 (1.06%)  149.57 - 153.713  190,476


Avg Volume (4 weeks):724,852
4 Weeks Range:135.23 - 156.01
4 Weeks Price Volatility (%):
52 Weeks Range:36.71 - 192.94
52 Weeks Price Volatility (%):
Average Price Target: 70.00
Price Target Upside/Downside: -80.73


No recent Headlines for this stock.

Business Background

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

  Be the first to like this.


3455  3160  739  1009 

Top 10 Active Counters
 GPACW 0.20-0.14 
 NTRSP 27.04-0.04 
 F 11.05+0.18 
 BAC 22.92-0.13 
 AMD 11.053-0.357 
 XLF 23.32-0.03 
 DCTH 0.030.00 
 PBR 8.58-0.38 
 TVIX 26.161-2.009 
 HUN 26.70-0.01 
Partners & Brokers